Fuente: Labiotech Lugar: In Depth A new wave of metabolic disease treatments beyond GLP-1 agonists is emerging to address the unmet needs of patients.
The post Beyond GLP-1s: is there a new wave of metabolic disease treatments?  appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.